Navigation path

Additional tools



    Profile of registrant

GlaxoSmithKline

Identification number in the register: 7990322925-77
Registration date: 06/01/2009 16:12:35

The information on this entity was last modified on: 27/04/2015 10:18:31
The date of the last annual update was: 27/04/2015 10:18:31
Next update due latest on: 27/04/2016

    Registrant : Organisation or self-employed individual

GlaxoSmithKline

GSK

Corporation

    Section of registration

II - In-house lobbyists and trade/business/professional associations

Companies & groups

    Contact details

Great West Road, 980
Brentford, Middlesex TW8 9GS
UNITED KINGDOM

(+44) 20 8047 5000

Avenue des Arts 46/b9
Brussels 1000
BELGIUM

(+32) 2 282 40 55

    Person with legal responsibility

Mr  Andrew Witty

Chief Executive Officer

    Person in charge of EU relations

Ms  Sue Middleton

Vice President European Government Affairs

    Goals / remit

GSK is a science-led global healthcare company.

Our mission is to help people do more, feel better, live longer.


We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare that can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute to the prosperity of their communities.

Our Pharmaceuticals business develops and makes medicines to treat a broad range of acute and chronic diseases. Our portfolio is made up of both patent-protected and off patent medicines and we have leading global positions in respiratory disease and HIV.

Our Vaccines business is one of the largest in the world. We have a broad portfolio of over 30 paediatric, adolescent, adult and travel vaccines. In 2014, we distributed approximately 800 million doses in 170 countries.

We develop and market a range of consumer healthcare products based on scientific innovation. We have brands in four main categories: Wellness, Oral Health, Skin Health and Nutrition. These include a number of well-known brands such as Sensodyne, Panadol and Horlicks.


We have a significant global presence with commercial operations in more than 150 countries, a network of 84 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.

global

    Specific activities covered by the Register

We follow EU initiatives, policies and legislative files related to our Pharmaceuticals, Vaccines and Consumer Healthcare businesses.

This includes topics such as R&D and clinical trials, antimicrobial resistance, data protection, pharmaceutical legislation, medical devices, trade & IP, environment, smoking cessation.

Mainly via the participation of events organized by Trade Associations and Think-Tanks.


 

No

No

EC Expert Group on Rare-Diseases (on behalf of EuropaBio)

No

No

    Number of persons involved in the activities described in the box above

100%: 0   75%: 3   50%: 3   25%: 5

11

5

The number of persons reflects the full time employment falling under the scope of the register. GSK follows the guidelines provided by EFPIA regarding this registration.

    Persons accredited for access to European Parliament premises

First name Surname Start Date End Date
Paulus Lambertus Antonius van Hoof 02/08/2014 31/07/2015
Sophie Renee Jeanne Marie Philippine Crousse 03/09/2014 28/08/2015
Karin Jeanette Drielsma 06/08/2014 04/08/2015
Guilherme Monteiro Ferreira Borges Dos Santos 30/09/2014 26/09/2015
Diana Mereu 04/10/2014 02/10/2015
Christian Baracat 26/08/2014 19/08/2015
Gisela Payeras Bailly 26/08/2014 19/08/2015
Nicholas Collinge Crosby 08/10/2014 06/10/2015

    Fields of interest

  • Competition
  • Consumer Affairs
  • Customs
  • Economic and Financial Affairs
  • Employment and Social Affairs
  • Enlargement
  • Enterprise
  • Environment
  • External Relations
  • Food Safety
  • General and Institutional Affairs
  • Humanitarian Aid
  • Information Society
  • Internal Market
  • Public Health
  • Regional Policy
  • Research and Technology
  • Taxation
  • Trade

    Membership and affiliation

American Chamber of Commerce to the European Union (AmChamEU)
Association of the European Self-Medication Industry (AESGP)
British Chamber of Commerce in Belgium
Cosmetics Europe
EuropaBio
European Biopharmaceutical Enterprises (EBE)
European Brands Association (AIM)
European Diagnostic Manufacturers Association (EDMA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Vaccines Europe (VE)
World Federation of Advertisers (WFA)

    Financial data

01/2014  -  12/2014

1,500,000 € - 1,999,999 €

0 €

N/A

10,445,466 €

FP7-People; FP7-NMP; Horizon 2020

In 2013, GSK’s estimated costs attributable to activities covered by the Register were in the range of 600.000-700.000. While GSK maintained activities in scope of the register from 2013 to 2014, the increased figures result from vacancies and the renewed “transparency register implementing guidelines” published 21 January 2015 by the Joint Transparency Register Secretariat.
GSK followed EFPIA’s interpretation and guidance on implementing those guidelines in 2014.

    Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.